AMED

Amedisys

Delisted

AMED was delisted on the 14th of August, 2025.

283 hedge funds and large institutions have $3.9B invested in Amedisys in 2019 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 106 increasing their positions, 104 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding:

3% less first-time investments, than exits

New positions opened: 31 | Existing positions closed: 32

44% less call options, than puts

Call options by funds: $23.8M | Put options by funds: $42.2M

Holders
283
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$23.8M
Puts
$42.2M
Net Calls
Net Calls Change

Top Buyers

1 +$84.6M
2 +$71.2M
3 +$27.7M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$18.6M
5
BlackRock
BlackRock
New York
+$16.9M
Name Holding Trade Value Shares
Change
Change in
Stake
176
$707K
177
$705K
178
$694K
179
$682K
180
$668K
181
$667K
182
$666K
183
$664K
184
$655K
185
$631K
186
$626K
187
$590K
188
$560K
189
$550K
190
$550K
191
$541K
192
$525K
193
$521K
194
$520K
195
$507K
196
$489K
197
$473K
198
$456K
199
$445K
200
$426K